Reuters logo
BRIEF-Glenmark to initiate clinical study for GBR 1342
2017年5月15日 / 中午12点15分 / 4 个月前

BRIEF-Glenmark to initiate clinical study for GBR 1342

May 15 (Reuters) - Glenmark Pharmaceuticals Ltd

* Glenmark pharmaceuticals to initiate clinical study for gbr 1342, second investigational new drug from immuno-oncology portfolio Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below